---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-22-000026"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2022-05-25T23:59:59+00:00"
generated_at: "2026-06-25T07:21:38.472954+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Haemonetics principal accounting officer Dan Goldstein to depart Aug 9, 2022

## Summary
- Dan Goldstein, VP Corporate Controller and Principal Accounting Officer, will leave on August 9, 2022.
- Goldstein will remain in his current role while the company searches for his successor.
- No reason for departure stated; no replacement named yet.

## SEC filing metadata
- accession: 0000313143-22-000026
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2022-05-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314322000026/0000313143-22-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314322000026/hae-20220520.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-22-000026
- JSON: https://secwatch.observer/filing/0000313143-22-000026.json
- Plain text: https://secwatch.observer/filing/0000313143-22-000026.txt

## Key facts
- Executive change
  Dan Goldstein departed as Vice President, Corporate Controller and Principal Accounting Officer at HAEMONETICS CORP.
  - Action: will leave
  - Role: Vice President, Corporate Controller and Principal Accounting Officer
  source text: Dan Goldstein, Vice President, Corporate Controller and Principal Accounting Officer will leave Haemonetics Corporation (the “Company”) on August 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314322000026/0000313143-22-000026-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.